483
Intas Pharmaceuticals LimitedFDA 483 - Intas Pharmaceuticals Limited - July 31, 2017
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
An FDA inspection of Intas Pharmaceuticals Limited in Ahmedabad, Gujarat, India, revealed a deficiency in sampling procedures for raw materials. Specifically, the firm's method for collecting composite samples from raw material containers was found to be inadequate. This indicates a potential issue with quality control and adherence to established sampling protocols.
Open in Dashboard
ID · 4f76e2d8-eaeb-4ac2-a891-807bdf0b6f08